|
|
Other links at Articles > Hematology-Oncology |
| 2. |
Breast Cancer Gene-Expression Assays Show Promise but More Data Are Needed
|
|
|
Gene-expression profiling assays in early-stage breast cancer have shown potential in improving predictions of prognosis and treatment benefit, but more information is needed about how they are best incorporated into decision making about current breast cancer treatment. Medscape Medical News
|
| 3. |
International Approvals: Torisel, Rocephin, Sigmart
|
|
|
Europe has approved temsirolimus injection (Torisel); Japan has approved a new dosing regimen for ceftriaxone injection (Rocephin) and an expanded indication for nicorandil injection (Sigmart). Medscape Medical News
|
|
|